This study establishes a pH-responsive, PD-L1/EGFR-targeted, ER-homing SLN platform co-delivering CB, miR, and R as a potent strategy to reprogram the immunosuppressive microenvironment of MSS CRC. The gene discussed is CD274; the disease is colorectal carcinoma.